Skip to main content

Increasing Prevalence of Chronic Disorders and Approval and Launch of New Products to Augment Growth of Medical Membrane Market

 


Advancements in medical sciences, rising incidences of fatal diseases, improvement in medical technology, growth in pharmaceutical and medical industry, increased demand for safe medicines and pharmaceutical products are some of the major driving forces that are expected to drive the medical membrane industry for hematological application and other pharmaceutical purification process.

Medical membranes, which help to safeguard different biological resources are extremely important as they help in protecting our health from various deadly and contagious diseases. These applications include the manufacturing of customized biocompatible solutions for the protection and purification of biological fluids. This industry is witnessing an exponential growth with constant inflow of pharmaceutical products, research and development activities. As per the statistics, there has been a steady rise in the demand for medical devices, materials and equipment that are required for the purification of medicines. With the right purification procedure, the drugs present in the body can remain active and the harmful chemicals out of the system can be avoided.

Market Dynamics

Increasing prevalence of chronic disorders is expected to propel growth of the global medical membrane market. For instance, according to the study, ‘Risk Factors and Rate of Progression of CKD in Children’, published in June 2019 in Kidney International Reports, 38% children experienced progression of chronic kidney disease within 2 years of follow-up.

The global medical membrane market is witnessing several M&A activities. For instance, in December 2020, Collagen Matrix, Inc., a regenerative, collagen-based, xenograft-derived medical devices provider, acquired Sunstar's Degradable Solutions division including its GUIDOR branded line of resorbable synthetic medical implants. Similarly, in January 2021, Blue Earth Diagnostics, a Bracco company, signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in radiopharmaceuticals and radiopharmaceutical technologies, and the Technical University of Munich, to acquire exclusive, worldwide rights to therapeutic applications of novel radiohybrid Prostate-Specific Membrane Antigen technology in prostate cancer.

Among regions, North America is expected to witness significant growth in the global medical membrane market, owing to high prevalence of cancer in the region. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Competitive Analysis

Major players operating in the global medical membrane market include, Nipro Corporation, Amniox, Pall Corporation, Sorin Group, Gore, OXGENE, Maquet Company, Merck Millipore, and others.

Major players operating in the global medical membrane market are focused on approval and launch of new products to expand their product portfolio. For instance, in January 2021, OXGENE, a biotechnology company offering integrated discovery and manufacturing technologies to the cell and gene therapy industry, launched its self-labelling integral membrane (SLIM) protein discovery system.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...
Post a Comment
Read more